Lung Cancer, Non-squamous, Non-small Cell
Oncology·MeSH: Lung Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Zongertinib | ENANTA PHARMACEUTICALS INC (ENTA) |
Frequently asked questions
How many drugs are in development for Lung Cancer, Non-squamous, Non-small Cell?
BioSniper tracks 1 drug in development for Lung Cancer, Non-squamous, Non-small Cell across 1 company.
How many clinical trials target Lung Cancer, Non-squamous, Non-small Cell?
There are 1 clinical trial targeting Lung Cancer, Non-squamous, Non-small Cell tracked by BioSniper.
Deep-dive into Lung Cancer, Non-squamous, Non-small Cell
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis